Dr Robyn Prueitt, PhD, DABT
Dr. Prueitt is an expert in toxicology, human genetics, carcinogenesis, and human health risk assessment. At Gradient, her primary responsibilities include evaluating toxicology and epidemiology data for regulatory comment, human health risk assessment, and litigation projects.
Before joining Gradient, Dr. Prueitt worked as a research scientist at the Fred Hutchinson Cancer Research Center, where she designed and interpreted multi-species proteomic studies related to tumor biology and biomarker discovery. As a postdoctoral fellow at the National Cancer Institute’s Laboratory of Human Carcinogenesis, Dr. Prueitt performed genomic and molecular epidemiologic studies of human cancer risk and progression. As a pre-doctoral student, she investigated genetic causes of human diseases using various molecular genetic techniques. Dr. Prueitt has authored many peer-reviewed articles in the fields of toxicology, genetics, and carcinogenesis.